Evidence-Based Complementary and Alternative Medicine / 2018 / Article / Tab 2

Research Article

A Randomized Double-Blind Placebo-Controlled Trial to Evaluate Prophylactic Effect of Traditional Chinese Medicine Supplementing Qi and Hemostasis Formula on Gastrointestinal Bleeding after Percutaneous Coronary Intervention in Patients at High Risks

Table 2

Medical history.

Treatment (N=59)Control (N=58)StatisticP value

Hypertension N(%)45(76.27)42(72.41)0.23(X2)0.6328
Type-2 DM N(%)32(54.24)33(56.90)0.08(X2)0.7723
Lipid disorder N(%)14(23.73)14(24.14)0.00(X2)0.9586
Chronic heart dysfunction N(%)14(23.73)14(24.14)0.00(X2)0.9586
Chronic kidney dysfunction N(%)16(27.12)15(25.86)0.02(X2)0.8776
Chronic bronchitis N(%)5(8.47)4(6.90)-(Fisher)1.0000
Anemia N(%)3(5.08)1(1.72)-(Fisher)0.6185
Prior cerebrovascular disease N(%)24(40.68)15(25.86)2.89(X2)0.0892
Prior peptic ulcer N(%)5(8.47)3(5.17)-(Fisher)0.7168
Prior smoking N(%)20(33.90)20(34.48)0.00(X2)0.9469
Prior alcohol intake N(%)13(22.03)11(18.97)0.17(X2)0.6811

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.